Unit
- Drug delivery system: A formulation or device that controls the rate, time, and place of drug release in the body. These systems aim to enhance therapeutic efficacy and reduce toxicity by optimizing drug concentration at the target site.
- Conventional vs. controlled delivery: Conventional dosage forms (tablets, injections) release drug rapidly, often leading to fluctuating plasma levels. Controlled delivery systems provide sustained release, reducing dosing frequency and maintaining drug levels within the therapeutic window.
- Key benefits: Improved patient compliance through fewer doses, reduced side effects due to localized delivery, protection of drugs from degradation, and enhanced bioavailability for poorly soluble compounds.
- Historical evolution: First-generation systems (1970s) focused on oral sustained release. Second generation introduced transdermal patches and implants. Third generation employs nanotechnology and stimuli-responsive materials for precision delivery.
- Classification: Systems can be categorized by route (oral, parenteral, transdermal), release mechanism (diffusion, dissolution, osmosis), and carrier type (liposomes, polymers, micelles).
- Therapeutic areas: Drug delivery innovations impact oncology (targeted chemotherapy), diabetes (insulin pumps), pain management (transdermal analgesics), and infectious diseases (long-acting antiretrovirals).
- Challenges: Overcoming biological barriers like the blood-brain barrier, achieving cell-specific targeting, scaling up manufacturing, and ensuring stability during storage are ongoing hurdles.
- Future directions: Personalized drug delivery using patient-specific biomarkers, closed-loop systems with real-time monitoring, and biodegradable materials to avoid device removal.
- Formulation considerations: Drug physicochemical properties such as solubility, molecular size, and charge dictate carrier selection. Polymeric nanoparticles, lipid-based vesicles, and hydrogels are tuned for release kinetics. Excipients must be biocompatible, and the formulation must withstand sterilization processes without compromising drug integrity.
- Regulatory and quality aspects: Drug delivery systems require rigorous characterization of particle size, encapsulation efficiency, and release profiles. Regulatory agencies demand stability data, impurity profiling, and in vivo correlation studies. Scale up from lab to production introduces variability that must be controlled through robust process analytical technology.
- Materials for controlled release: Biodegradable polymers like PLGA and polylactide degrade into safe byproducts, enabling zero order release. Stimuli responsive materials such as pH sensitive hydrogels or temperature responsive polymers allow triggered drug release at disease sites, reducing systemic exposure and improving therapeutic indices.
Code Example
Python
# Simulate plasma concentration over time for a single oral dose
import numpy as np
import matplotlib.pyplot as plt
def plasma_concentration(dose, Vd, ka, ke, t):
# dose: mg, Vd: volume of distribution (L), ka: absorption rate (1/h), ke: elimination rate (1/h), t: time array
return (dose * ka / (Vd * (ka - ke))) * (np.exp(-ke * t) - np.exp(-ka * t))
time = np.linspace(0, 24, 100)
conc = plasma_concentration(500, 50, 1.5, 0.2, time)
plt.plot(time, conc)
plt.xlabel('Time (h)')
plt.ylabel('Concentration (mg/L)')
plt.title('Simulated Plasma Profile')
plt.show()This Python code simulates a one-compartment pharmacokinetic model with first-order absorption and elimination. It calculates plasma concentration over 24 hours for a 500 mg dose, using typical absorption and elimination rates. The plot visualizes the peak concentration and elimination phase.
Quick Revision
- Drug delivery systems control release rate, location, and duration to improve therapy.
- Conventional systems cause fluctuating drug levels; controlled systems maintain steady concentrations.
- Benefits include better compliance, reduced side effects, and protection of drugs.
- Systems evolved from sustained release to smart nanocarriers.
- Classification based on route, mechanism, and carrier type.
- Applications span oncology, diabetes, pain, and infectious diseases.